DOWNERS GROVE, Ill., – Dover announced that it has entered into a definitive agreement to acquire Malema Engineering Corporation, a designer and manufacturer of flow-measurement and control instruments serving customers in the biopharmaceutical, semiconductor and industrial sectors. Malema will become part of the PSG business unit within Dover’s Pumps & Process Solutions segment.

Malema’s products will expand Dover’s biopharma single-use production offering, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters. Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea, and India, Malema expects to generate approximately $40-45 million in revenue during the full year 2022 and has a robust growth outlook.

Speaking about the market opportunity for Malema, PSG’s President, Karl Buscher, said, “We see a tremendous long-term growth opportunity in the bioprocessing industry driven by a strong and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, as well as budding cell & gene therapies. Additionally, the growing adoption of more efficient single-use production processes supports a robust outlook for our offerings of single-use components to end-customers. We believe that pairing Malema’s technology with our existing portfolio of single-use pumps for biopharma processing will greatly enhance the accuracy and value proposition of our solutions to our customers.”